Regeneron submits BLA for VEGF Trap-Eye in wet AMD, but investors unimpressed
23 February 2011
Donna Young
Please Login to read the full article.
23 February 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE to review Fabre's Javlor again as comparison with unlicensed drugs deemed unfair
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Gilenya and Tasigna drive new product growth at Novartis
- Bayer/J&J report positive Xarelto results in Japanese AF patients
